The article by Jeffrey Moore, DC, and Charles Blum, DC, raises a careful clinical question: how should CMRT uterine or prostate applications be approached when a patient is undergoing or has undergone gender-affirming surgery, hormonal care, or both? The answer starts with respect, but it cannot stop there. It also requires accurate anatomy, informed consent, clear communication, and a more thoughtful intake process.